{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T13:23:50Z","timestamp":1769520230492,"version":"3.49.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2015,5,11]],"date-time":"2015-05-11T00:00:00Z","timestamp":1431302400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2015,5,11]],"date-time":"2015-05-11T00:00:00Z","timestamp":1431302400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1038\/bmt.2015.106","type":"journal-article","created":{"date-parts":[[2015,5,11]],"date-time":"2015-05-11T13:44:25Z","timestamp":1431351865000},"page":"1075-1082","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":38,"title":["High-dose therapy and autologous stem cell transplant in older adults with multiple myeloma"],"prefix":"10.1038","volume":"50","author":[{"given":"T M","family":"Wildes","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J D","family":"Finney","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Fiala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R","family":"Vij","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7234-1715","authenticated-orcid":false,"given":"K","family":"Stockerl-Goldstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K R","family":"Carson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"Mikhael","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G","family":"Colditz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,5,11]]},"reference":[{"key":"BFbmt2015106_CR1","doi-asserted-by":"publisher","first-page":"2758","DOI":"10.1200\/JCO.2008.20.8983","volume":"27","author":"BD Smith","year":"2009","unstructured":"Smith BD, Smith GL, Hurria A, Hortobagyi GN, Buchholz TA . Future of cancer incidence in the United States: burdens upon an aging, changing nation. J Clin Oncol 2009; 27: 2758\u20132765.","journal-title":"J Clin Oncol"},{"key":"BFbmt2015106_CR2","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.1634\/theoncologist.2011-0229","volume":"16","author":"D Pulte","year":"2011","unstructured":"Pulte D, Gondos A, Brenner H . Improvement in survival of older adults with multiple myeloma: results of an updated period analysis of SEER data. Oncologist 2011; 16: 1600\u20131603.","journal-title":"Oncologist"},{"key":"BFbmt2015106_CR3","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1038\/leu.2013.313","volume":"28","author":"SK Kumar","year":"2014","unstructured":"Kumar SK, Dispenzieri A, Lacy MQ, Gertz MA, Buadi FK, Pandey S et al. Continued improvement in survival in multiple myeloma: changes in early mortality and outcomes in older patients. Leukemia 2014; 28: 1122\u20131128.","journal-title":"Leukemia"},{"key":"BFbmt2015106_CR4","doi-asserted-by":"publisher","first-page":"21","DOI":"10.4065\/78.1.21","volume":"78","author":"RA Kyle","year":"2003","unstructured":"Kyle RA, Gertz MA, Witzig TE, Lust JA, Lacy MQ, Dispenzieri A et al. Review of 1027 patients with newly diagnosed multiple myeloma. Mayo Clin Proc 2003; 78: 21\u201333.","journal-title":"Mayo Clin Proc"},{"key":"BFbmt2015106_CR5","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1038\/sj.bmt.1705486","volume":"38","author":"HD Klepin","year":"2006","unstructured":"Klepin HD, Hurd DD . Autologous transplantation in elderly patients with multiple myeloma: are we asking the right questions? Bone Marrow Transplant 2006; 38: 585\u2013592.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2015106_CR6","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1056\/NEJM199607113350204","volume":"335","author":"M Attal","year":"1996","unstructured":"Attal M, Harousseau JL, Stoppa AM, Sotto JJ, Fuzibet JG, Rossi JF et al. A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. Intergroupe Fran\u00e7ais du My\u00e9lome. N Engl J Med 1996; 335: 91\u201397.","journal-title":"N Engl J Med"},{"key":"BFbmt2015106_CR7","doi-asserted-by":"publisher","first-page":"1875","DOI":"10.1056\/NEJMoa022340","volume":"348","author":"JA Child","year":"2003","unstructured":"Child JA, Morgan GJ, Davies FE, Owen RG, Bell SE, Hawkins K et al. High-dose chemotherapy with hematopoietic stem-cell rescue for multiple myeloma. N Engl J Med 2003; 348: 1875\u20131883.","journal-title":"N Engl J Med"},{"key":"BFbmt2015106_CR8","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.transproceed.2010.12.031","volume":"43","author":"S Roncon","year":"2011","unstructured":"Roncon S, Barbosa IL, Campilho F, Lopes SM, Campos A, Carvalhais A . Mobilization and collection of peripheral blood stem cells in multiple myeloma patients older than 65 years. Transplant Proc 2011; 43: 244\u2013246.","journal-title":"Transplant Proc"},{"key":"BFbmt2015106_CR9","doi-asserted-by":"publisher","first-page":"30","DOI":"10.5144\/1658-3876.2011.30","volume":"4","author":"ElJ Cheikh","year":"2011","unstructured":"Cheikh ElJ, Kfoury E, Calmels B, Lemarie C, Stoppa A-M, Bouabdallah R et al. Age at transplantation and outcome after autologous stem cell transplantation in elderly patients with multiple myeloma. Hematol Oncol Stem Cell Ther 2011; 4: 30\u201336.","journal-title":"Hematol Oncol Stem Cell Ther"},{"key":"BFbmt2015106_CR10","doi-asserted-by":"publisher","first-page":"118","DOI":"10.3109\/10428194.2011.606942","volume":"53","author":"Q Bashir","year":"2012","unstructured":"Bashir Q, Shah N, Parmar S, Wei W, Rondon G, Weber DM et al. Feasibility of autologous hematopoietic stem cell transplant in patients aged\u2265 70 years with multiple myeloma. Leuk Lymphoma 2012; 53: 118\u2013122.","journal-title":"Leuk Lymphoma"},{"key":"BFbmt2015106_CR11","doi-asserted-by":"publisher","first-page":"63","DOI":"10.2169\/internalmedicine.52.8390","volume":"52","author":"T Muta","year":"2013","unstructured":"Muta T, Miyamoto T, Fujisaki T, Ohno Y, Kamimura T, Kato K et al. Evaluation of the feasibility and efficacy of autologous stem cell transplantation in elderly patients with multiple myeloma. Intern Med 2013; 52: 63\u201370.","journal-title":"Intern Med"},{"key":"BFbmt2015106_CR12","first-page":"66","volume":"26","author":"JF Piccirillo","year":"1999","unstructured":"Piccirillo JF, Creech CM, Zequeira R, Anderson S, Johnston AS . Inclusion of comorbidity into oncology data registries. J Registry Manage 1999; 26: 66\u201370.","journal-title":"J Registry Manage"},{"key":"BFbmt2015106_CR13","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1097\/00000421-198212000-00014","volume":"5","author":"MM Oken","year":"1982","unstructured":"Oken MM, Creech RH, Tormey DC, Horton J, Davis TE, McFadden ET et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 1982; 5: 649\u2013655.","journal-title":"Am J Clin Oncol"},{"key":"BFbmt2015106_CR14","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1093\/annonc\/mdm011","volume":"18","author":"V Launay-Vacher","year":"2007","unstructured":"Launay-Vacher V, Chatelut E, Lichtman SM, Wildiers H, Steer C, Aapro M et al. Renal insufficiency in elderly cancer patients: International Society of Geriatric Oncology clinical practice recommendations. Ann Oncol 2007; 18: 1314\u20131321.","journal-title":"Ann Oncol"},{"key":"BFbmt2015106_CR15","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1002\/1097-0142(197509)36:3<842::AID-CNCR2820360303>3.0.CO;2-U","volume":"36","author":"BG Durie","year":"1975","unstructured":"Durie BG, Salmon SE . A clinical staging system for multiple myeloma. Correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival. Cancer 1975; 36: 842\u2013854.","journal-title":"Cancer"},{"key":"BFbmt2015106_CR16","doi-asserted-by":"publisher","first-page":"3412","DOI":"10.1200\/JCO.2005.04.242","volume":"23","author":"PR Greipp","year":"2005","unstructured":"Greipp PR . International Staging System for Multiple Myeloma. J Clin Oncol 2005; 23: 3412\u20133420.","journal-title":"J Clin Oncol"},{"key":"BFbmt2015106_CR17","volume-title":"Statistical Analysis with Missing Data","author":"R Little","year":"1987","unstructured":"Little R, Rubin DB . Statistical Analysis with Missing Data. J. Wiley & Sons: New York, NY, USA, 1987."},{"key":"BFbmt2015106_CR18","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1093\/biomet\/70.1.41","volume":"70","author":"P Rosenbaum","year":"1983","unstructured":"Rosenbaum P, Rubin D . The central role of the propensity score in observational studies for causal effects. Biometrika 1983; 70: 41\u201355.","journal-title":"Biometrika"},{"key":"BFbmt2015106_CR19","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/ki.2011.388","volume":"81","author":"J Liu","year":"2012","unstructured":"Liu J, Weinhandl ED, Gilbertson DT, Collins AJ St, Peter WL . Issues regarding \u201cimmortal time\u201d in the analysis of the treatment effects in observational studies. Kidney Int 2012; 81: 341\u2013350.","journal-title":"Kidney Int"},{"key":"BFbmt2015106_CR20","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1016\/j.jdiacomp.2013.07.007","volume":"27","author":"EJ Boyko","year":"2013","unstructured":"Boyko EJ . Observational research \u2014 opportunities and limitations. J Diabetes Complications 2013; 27: 642\u2013648.","journal-title":"J Diabetes Complications"},{"key":"BFbmt2015106_CR21","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1093\/annonc\/mdt509","volume":"25","author":"M Merz","year":"2014","unstructured":"Merz M, Neben K, Raab MS, Sauer S, Egerer G, Hundemer M et al. Autologous stem cell transplantation for elderly patients with newly diagnosed multiple myeloma in the era of novel agents. Ann Oncol 2014; 25: 189\u2013195.","journal-title":"Ann Oncol"},{"key":"BFbmt2015106_CR22","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1002\/ajh.21191","volume":"83","author":"SK Kumar","year":"2008","unstructured":"Kumar SK, Dingli D, Lacy MQ, Dispenzieri A, Hayman SR, Buadi FK et al. Autologous stem cell transplantation in patients of 70 years and older with multiple myeloma: results from a matched pair analysis. Am J Hematol 2008; 83: 614\u2013617.","journal-title":"Am J Hematol"},{"key":"BFbmt2015106_CR23","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1038\/sj.bmt.1705627","volume":"39","author":"MA Gertz","year":"2007","unstructured":"Gertz MA, Lacy MQ, Dispenzieri A, Hayman SR, Kumar S, Leung N et al. Impact of age and serum creatinine value on outcome after autologous blood stem cell transplantation for patients with multiple myeloma. Bone Marrow Transplant 2007; 39: 605\u2013611.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2015106_CR24","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1038\/sj.bmt.1704728","volume":"35","author":"M Krejci","year":"2005","unstructured":"Krejci M, Buchler T, Hajek R, Svobodnik A, Krivanova A, Pour L et al. Autologous bone marrow transplantation in multiple myeloma: a single centre experience of 23 patients. Bone Marrow Transplant 2005; 35: 159\u2013164.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2015106_CR25","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1111\/j.1365-2141.2006.06042.x","volume":"133","author":"S Lenhoff","year":"2006","unstructured":"Lenhoff S, Hjorth M, Westin J, Brinch L, Backstrom B, Carlson K et al. Impact of age on survival after intensive therapy for multiple myeloma: a population-based study by the Nordic Myeloma Study Group. Br J Haematol 2006; 133: 389\u2013396.","journal-title":"Br J Haematol"},{"key":"BFbmt2015106_CR26","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1016\/S0140-6736(07)61537-2","volume":"370","author":"T Facon","year":"2007","unstructured":"Facon T, Mary JY, Hulin C, Benboubker L, Attal M, Pegourie B et al. Melphalan and prednisone plus thalidomide versus melphalan and prednisone alone or reduced-intensity autologous stem cell transplantation in elderly patients with multiple myeloma (IFM 99\u201306): a randomised trial. Lancet 2007; 370: 1209\u20131218.","journal-title":"Lancet"},{"key":"BFbmt2015106_CR27","doi-asserted-by":"publisher","first-page":"1873","DOI":"10.1182\/blood-2009-09-241737","volume":"115","author":"A Palumbo","year":"2010","unstructured":"Palumbo A, Bringhen S, Bruno B, Falcone AP, Liberati AM, Grasso M et al. Melphalan 200mg\/m(2) versus melphalan 100mg\/m(2) in newly diagnosed myeloma patients: a prospective, multicenter phase 3 study. Blood 2010; 115: 1873\u20131879.","journal-title":"Blood"},{"key":"BFbmt2015106_CR28","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1159\/000357394","volume":"132","author":"S Ozaki","year":"2014","unstructured":"Ozaki S, Harada T, Saitoh T, Shimazaki C, Itagaki M, Asaoku H et al. Survival of multiple myeloma patients aged 65-70 years in the era of novel agents and autologous stem cell transplantation. A multicenter retrospective collaborative study of the Japanese Society of Myeloma and the European Myeloma Network. Acta Haematol 2014; 132: 211\u2013219.","journal-title":"Acta Haematol"},{"key":"BFbmt2015106_CR29","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1001\/jama.1963.03060120024016","volume":"185","author":"S Katz","year":"1963","unstructured":"Katz S, Ford AB, Moskowitz R, Jackson B, Jaffe M . Studies of Illness in the Aged: The Index of ADL. JAMA 1963; 185: 914\u2013919.","journal-title":"JAMA"},{"key":"BFbmt2015106_CR30","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1093\/geront\/9.3_Part_1.179","volume":"9","author":"M Lawton","year":"1969","unstructured":"Lawton M, Brody E . Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist 1969; 9: 179\u2013986.","journal-title":"Gerontologist"},{"key":"BFbmt2015106_CR31","doi-asserted-by":"publisher","first-page":"3457","DOI":"10.1200\/JCO.2011.34.7625","volume":"29","author":"A Hurria","year":"2011","unstructured":"Hurria A, Togawa K, Mohile SG, Owusu C, Klepin HD, Gross CP et al. Predicting Chemotherapy Toxicity in Older Adults With Cancer: a prospective multicenter study. J Clin Oncol 2011; 29: 3457\u20133465.","journal-title":"J Clin Oncol"},{"key":"BFbmt2015106_CR32","doi-asserted-by":"publisher","first-page":"3377","DOI":"10.1002\/cncr.26646","volume":"118","author":"M Extermann","year":"2012","unstructured":"Extermann M, Boler I, Reich RR, Lyman GH, Brown RH, DeFelice J et al. Predicting the risk of chemotherapy toxicity in older patients: the Chemotherapy Risk Assessment Scale for High-Age Patients (CRASH) score. Cancer 2012; 118: 3377\u20133386.","journal-title":"Cancer"},{"key":"BFbmt2015106_CR33","doi-asserted-by":"publisher","first-page":"980","DOI":"10.3324\/haematol.2012.075051","volume":"98","author":"S Bringhen","year":"2013","unstructured":"Bringhen S, Mateos M-V, Zweegman S, Larocca A, Falcone AP, Oriol A et al. Age and organ damage correlate with poor survival in myeloma patients: meta-analysis of 1435 individual patient data from 4 randomized trials. Haematologica 2013; 98: 980\u2013987.","journal-title":"Haematologica"},{"key":"BFbmt2015106_CR34","doi-asserted-by":"publisher","first-page":"e35","DOI":"10.1038\/bcj.2011.34","volume":"1","author":"M Kleber","year":"2011","unstructured":"Kleber M, Ihorst G, Terhorst M, Koch B, Deschler B, W\u00e4sch R et al. Comorbidity as a prognostic variable in multiple myeloma: comparative evaluation of common comorbidity scores and use of a novel MM\u2013comorbidity score. Blood Cancer J 2011; 1: e35\u2013e38.","journal-title":"Blood Cancer J"},{"key":"BFbmt2015106_CR35","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/j.clml.2013.03.013","volume":"13","author":"M Kleber","year":"2013","unstructured":"Kleber M, Ihorst G, Gro\u00df B, Koch B, Reinhardt H, W\u00e4sch R et al. Validation of the Freiburg Comorbidity Index in 466 multiple myeloma patients and combination with the international staging system are highly predictive for outcome. Clin Lymphoma Myeloma Leuk 2013; 13: 541\u2013551.","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"BFbmt2015106_CR36","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1038\/sj.bmt.1705360","volume":"37","author":"E Jantunen","year":"2006","unstructured":"Jantunen E, Kuittinen T, Penttil\u00e4 K, Lehtonen P, Mahlam\u00e4ki E, Nousiainen T . High-dose melphalan (200mg\/m2) supported by autologous stem cell transplantation is safe and effective in elderly (\u2a7e65 years) myeloma patients: comparison with younger patients treated on the same protocol. Bone Marrow Transplant 2006; 37: 917\u2013922.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2015106_CR37","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1038\/sj.bmt.1703818","volume":"31","author":"E Terpos","year":"2003","unstructured":"Terpos E, Apperley JF, Samson D, Giles C, Crawley C, Kanfer E et al. Autologous stem cell transplantation in multiple myeloma: improved survival in nonsecretory multiple myeloma but lack of influence of age, status at transplant, previous treatment and conditioning regimen. A single-centre experience in 127 patients. Bone Marrow Transplant 2003; 31: 163\u2013170.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2015106_CR38","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1038\/sj.bmt.1704288","volume":"32","author":"DE Reece","year":"2003","unstructured":"Reece DE, Bredeson C, P\u00e9rez WS, Jagannath S, Zhang M-J, Ballen KK et al. Autologous stem cell transplantation in multiple myeloma patients \/=60 years of age. Bone Marrow Transplant 2003; 32: 1135\u20131143.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2015106_CR39","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1038\/sj.bmt.1705307","volume":"37","author":"D O'Shea","year":"2006","unstructured":"O'Shea D, Giles C, Terpos E, Perz J, Politou M, Sana V et al. Predictive factors for survival in myeloma patients who undergo autologous stem cell transplantation: a single-centre experience in 211 patients. Bone Marrow Transplant 2006; 37: 731\u2013737.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2015106_CR40","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1111\/j.1600-0609.2010.01418.x","volume":"84","author":"M Offidani","year":"2010","unstructured":"Offidani M, Leoni P, Corvatta L, Polloni C, Gentili S, Savini A et al. ThaDD plus high dose therapy and autologous stem cell transplantation does not appear superior to ThaDD plus maintenance in elderly patients with de novo multiple myeloma. Eur J Haematol 2010; 84: 474\u2013483.","journal-title":"Eur J Haematol"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/bmt2015106.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/bmt2015106","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/bmt2015106.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,23]],"date-time":"2022-03-23T18:15:21Z","timestamp":1648059321000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/bmt2015106"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5,11]]},"references-count":40,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2015,8]]}},"alternative-id":["BFbmt2015106"],"URL":"https:\/\/doi.org\/10.1038\/bmt.2015.106","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,5,11]]},"assertion":[{"value":"19 November 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 February 2015","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 February 2015","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2015","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}